Through this participatory process, the project aims to explore solutions that respond to local needs while contributing to wider efforts to strengthen water resilience across the Mediterranean.
The RESWATER project continued its work in Egypt with a Living Lab held on 12 August 2026, bringing stakeholders together to exchange knowledge and discuss practical approaches to Non-Conventional Water Resources and more resilient urban water management.
Organised by the Ministry of Water Resources and Irrigation (MWRI), the Egyptian partner of RESWATER, the Living Lab provided an opportunity to engage relevant stakeholders in the project and create a space for discussion around the water challenges facing urban areas and the role that alternative water resources can play in addressing them.
Living Labs form an important part of the RESWATER approach, allowing project partners to work directly with stakeholders and bring together different perspectives, experiences and expertise. Through this participatory process, the project aims to explore solutions that respond to local needs while contributing to wider efforts to strengthen water resilience across the Mediterranean.
The session in Egypt focused on knowledge exchange, stakeholder engagement and the discussion of practical solutions related to Non-Conventional Water Resources (NCWR). These resources can complement conventional water supplies and support more sustainable approaches to managing increasing pressures on available water resources.
The Egyptian Living Lab represents another step in RESWATER’s work to connect technical project activities with the people and organisations involved in water management at national and local level.
Through similar activities across the project countries, RESWATER is building cooperation and knowledge exchange around practical approaches to more resilient urban water management across the Mediterranean.
Further information on the RESWATER Living Lab in Egypt is available from the Ministry of Water Resources and Irrigation.
Last Update
01/09/2026
Next Med